Short interest in Heron Therapeutics Inc (NASDAQ:HRTX) decreased during the last reporting period, falling from 35.96M to 35.92M. This put 30.62% of the company's publicly available shares short.

Short interest for Heron Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Heron Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.39M shares traded per day, it would take 25.88 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.